Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nicholas A. Brasher"'
Autor:
Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, Mohamed Hammoud, Chaturaka Rodrigo, Elizabeth Keoshkerian, Hui Li, Nicholas A. Brasher, Daniel Christ, Romain Rouet, Deborah Burnet, Branka Grubor-Bauk, William Rawlinson, Stuart Turville, Anupriya Aggarwal, Alberto Ospina Stella, Christina Fichter, Fabienne Brilot, Michael Mina, Jeffrey J. Post, Bernard Hudson, Nicky Gilroy, Dominic Dwyer, Sarah C. Sasson, Fiona Tea, Deepti Pilli, Anthony Kelleher, Nicodemus Tedla, Andrew R. Lloyd, Marianne Martinello, Rowena A. Bull
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 4, Pp 100228- (2021)
Summary: Considerable concerns relating to the duration of protective immunity against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) exist, with evidence of antibody titers declining rapidly after infection and reports of reinfection.
Externí odkaz:
https://doaj.org/article/f87c028de7894e22a0d1a4e95ff87962
Publikováno v:
Viruses, Vol 13, Iss 6, p 983 (2021)
Despite the advent of effective, curative treatments for hepatitis C virus (HCV), a preventative vaccine remains essential for the global elimination of HCV. It is now clear that the induction of broadly neutralising antibodies (bNAbs) is essential f
Externí odkaz:
https://doaj.org/article/2bc27399b32940408e536daa41171d7d
Autor:
Alexander P. Underwood, Melanie R. Walker, Nicholas A. Brasher, Auda A. Eltahla, Lisa Maher, Fabio Luciani, Andrew R. Lloyd, Rowena A. Bull
Publikováno v:
Viruses, Vol 10, Iss 11, p 659 (2018)
Despite recent advances in curative therapy, hepatitis C virus (HCV) still remains a global threat. In order to achieve global elimination, a prophylactic vaccine should be considered high priority. Previous immunogens used to induce broad neutralisi
Externí odkaz:
https://doaj.org/article/7504edf82f9d4ceeb4d7be91f361d1de
Autor:
Anurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, David Agapiou, Elvis Pandzic, Nicholas A. Brasher, Bentotage Samitha Madushan Fernando, Elizabeth Keoshkerian, Hui Li, Ha Na Kim, Megan Lord, Gordona Popovic, William Rawlinson, Michael Mina, Jeffrey J. Post, Bernard Hudson, Nicky Gilroy, Dominic Dwyer, Sarah C. Sasson, Branka Grubor-Bauk, Andrew R. Lloyd, Marianne Martinello, Rowena A. Bull, Nicodemus Tedla
Publikováno v:
The Journal of Immunology. 209:1499-1512
Phagocytic responses by effector cells to opsonized viruses have been recognized to play a key role in antiviral immunity. Limited data on coronavirus disease 2019 suggest that the role of Ab-dependent and -independent phagocytosis may contribute to
Autor:
Nicholas A. Brasher, Andrew R. Lloyd, Auda A. Eltahla, Simone Rizzetto, Heidi E. Drummer, Rowena A. Bull, Melanie R. Walker, Chaturaka Rodrigo, Alexander Underwood, Irene Boo, Nicodemus Tedla, Lisa Maher, Fabio Luciani
Publikováno v:
Journal of Hepatology. 72:670-679
Background & Aims Neutralising antibodies (NAbs) play a key role in clearance of HCV. NAbs have been isolated and mapped to several domains on the HCV envelope proteins. However, the immunodominance of these epitopes in HCV infection remains unknown,
Autor:
Anurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, David Agapiou, Elvis Pandzic, Nicholas A Brasher, Bentotage Samitha Madushan Fernando, Elizabeth Keoshkerian, Hui Li, Ha Na Kim, Megan Lord, Gordona Popovic, William Rawlinson, Michael Mina, Jeffrey J Post, Bernard Hudson, Nicole Gilroy, Adam W. Bartlett, Golo Ahlenstiel, Branka Grubor-Bauk, Dominic Dwyer, Pamela Konecny, Andrew R Lloyd, Marianne Martinello, Rowena A Bull, Nicodemus Tedla
Phagocytic responses by effector cells to antibody or complement-opsonised viruses have been recognized to play a key role in anti-viral immunity. These include antibody dependent cellular phagocytosis mediated via Fc-receptors, phagocytosis mediated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b68cede84327307ffc3e2dadec7e9dd
https://doi.org/10.1101/2021.12.21.473774
https://doi.org/10.1101/2021.12.21.473774
Autor:
Nicky Gilroy, Nicholas A. Brasher, Hui Li, Fabienne Brilot, Romain Rouet, Stuart Turville, Alberto Ospina Stella, Mohamed A. Hammoud, Arunasingam Abayasingam, Andrew R. Lloyd, Deepti Pilli, Chaturaka Rodrigo, Rowena A. Bull, Dominic E. Dwyer, Michael J. Mina, Bernard J Hudson, Sarah Christina Sasson, Nicodemus Tedla, Fiona Tea, Daniel Christ, Deborah Burnet, Anthony D. Kelleher, Harikrishnan Balachandran, Elizabeth Keoshkerian, William D. Rawlinson, Anupriya Aggarwal, Christina Fichter, Marianne Martinello, Jeffrey J. Post, Branka Grubor-Bauk, David Agapiou
Publikováno v:
Cell Reports Medicine
Cell Reports Medicine, Vol 2, Iss 4, Pp 100228-(2021)
Cell Reports Medicine, Vol 2, Iss 4, Pp 100228-(2021)
Considerable concerns relating to the duration of protective immunity against SARS-CoV-2 exist, with evidence of antibody titres declining rapidly after infection and reports of reinfection. Here we monitor the antibody responses against SARS-CoV-2 r
Autor:
Elizabeth Keoshkerian, William D. Rawlinson, Jeffrey J. Post, Michael J. Mina, Harikrishnan Balachandran, Andrew R. Lloyd, Bernard J Hudson, Hui Li, Branka Grubor-Bauk, Chaturaka Rodrigo, David Agapiou, Daniel Christ, Rowena A. Bull, Deborah L. Burnett, Sarah C. Sasson, Fabienne Brilot, Romain Rouet, Stuart Turville, Dominic M. Dwyer, Arunasingam Abayasingam, Marianne Martinello, Nicky Gilroy, Nicholas A. Brasher, Deepti Pilli, Fiona Tea, Anupriya Aggarwal, Nicodemus Tedla
Considerable concerns relating to the duration of protective immunity against SARS-CoV-2 have been raised, with evidence of antibody titres declining rapidly after infection and reports of reinfection. Here we monitored antibody responses against SAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09152ac110bcfcceb1b14c965959bfb3
https://hdl.handle.net/2123/24220
https://hdl.handle.net/2123/24220
Publikováno v:
Viruses
Viruses, Vol 13, Iss 983, p 983 (2021)
Viruses, Vol 13, Iss 983, p 983 (2021)
Despite the advent of effective, curative treatments for hepatitis C virus (HCV), a preventative vaccine remains essential for the global elimination of HCV. It is now clear that the induction of broadly neutralising antibodies (bNAbs) is essential f
Autor:
Rowena A. Bull, Auda A. Eltahla, Nicholas A. Brasher, Andrew R. Lloyd, Fabio Luciani, Arunasingam Abayasingam, Bing Ru Wu, Lisa Maher, Hui Li, Preston Leung, Alexander Underwood, Melanie R. Walker
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Hepatitis C virus (HCV) is one of very few viruses that are either naturally cleared, or alternatively persist to cause chronic disease. Viral diversity and escape, as well as host adaptive immune factors, are believed to control the outcome. To date